Search results for "Neurodegenerative Disease"

showing 10 items of 169 documents

The Blood–Brain Barrier as a Target in Traumatic Brain Injury Treatment

2014

Traumatic brain injury (TBI) is one of the most frequent causes of death in the young population. Several clinical trials have unsuccessfully focused on direct neuroprotective therapies. Recently immunotherapeutic strategies shifted into focus of translational research in acute CNS diseases. Cross-talk between activated microglia and blood–brain barrier (BBB) could initiate opening of the BBB and subsequent recruitment of systemic immune cells and mediators into the brain. Stabilization of the BBB after TBI could be a promising strategy to limit neuronal inflammation, secondary brain damage and acute neurodegeneration. This review provides an overview on the pathophysiology of TBI and brain…

Pathologymedicine.medical_specialtyTraumatic brain injuryPeroxisome Proliferator-Activated ReceptorsBrain EdemaInflammationBrain damageBlood–brain barrierNeuroprotectionRosiglitazoneReceptors GlucocorticoidmedicineHumansHypoglycemic AgentsMyosin-Light-Chain KinaseNeuroinflammationInflammationPioglitazoneMicrogliabusiness.industryNeurodegenerationNeurodegenerative DiseasesGeneral Medicinemedicine.diseaseCell HypoxiaNeuroprotective Agentsmedicine.anatomical_structurenervous systemBlood-Brain BarrierBrain InjuriesThiazolidinedionesmedicine.symptombusinessNeuroscienceArchives of Medical Research
researchProduct

Depressive Symptom Profiles Predict Specific Neurodegenerative Disease Syndromes in Early Stages

2020

Background: During early stages, patients with neurodegenerative diseases (NDG) often present with depressive symptoms. However, because depression is a heterogeneous disorder, more precise delineation of the specific depressive symptom profiles that arise early in distinct NDG syndromes is necessary to enhance patient diagnosis and care. Methods and Findings: Five-hundred and sixty four participants self-reported their depressive symptoms using the Geriatric Depression Scale (GDS), including 111 healthy older control subjects (NC) and 453 patients diagnosed with one of six NDGs who were at the mild stage of disease (CDR® Dementia Staging Instrument ≤ 1) [186 Alzheimer's disease (AD), 76 be…

PediatricsAgingDiseaseNeurodegenerativeAlzheimer's Diseasefrontotemporal dementialcsh:RC346-429Primary progressive aphasia0302 clinical medicineneurodegenerative diseasehopelessnessworry2.1 Biological and endogenous factorsPsychology030212 general & internal medicineAetiologyDepression (differential diagnoses)Original ResearchdysphoraDepressionAlzheimer'sFrontotemporal Dementia (FTD)Mental HealthNeurologyNeurologicaldepressionGeriatric Depression Scalemedicine.symptomFrontotemporal dementiamedicine.medical_specialtyClinical SciencesDysphoriaProgressive supranuclear palsy7.3 Management and decision making03 medical and health sciencesRare DiseasesClinical ResearchBehavioral and Social SciencemedicineAcquired Cognitive ImpairmentDementialcsh:Neurology. Diseases of the nervous systembusiness.industryNeurosciencesAlzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)progressive supranuclear palsymedicine.diseaseBrain DisordersGood Health and Well BeingDementiaNeurology (clinical)Management of diseases and conditionsbusiness030217 neurology & neurosurgeryFrontiers in Neurology
researchProduct

The close link between brain vascular pathological conditions and neurodegenerative diseases: Focus on some examples and potential treatments

2022

A close relationship is emerging among the age-related neurodegenerative decline, and the age-related typical alterations, dysfunctions, and related diseases of the cerobro-and/or cardiovascular system, which contributes in a significative manner to the triggering and progressing of neurodegenerative diseases (NeuroDegD). Specifically, macroinfarcts, microinfarcts, micro-hemorrhages (and particularly their number), atherosclerosis, arteriolosclerosis and cerebral amyloid angiopathy have been documented to be significantly associated with the onset of the cognitive impairment. In addition, vascular alterations and dysfunctions resulting in a reduced cerebral blood flow, and anomalies in the …

PharmacologyAlterations dysfunctions and related diseases of the cerobro-and/or cardiovascular systemBlood-Brain BarrierPotential treatmentsPhysiologyBrain blood barrier (BBB)Neurodegenerative diseasesHumansSettore MED/05 - Patologia ClinicaMolecular MedicineNeurovascular unit (NVU)Vascular Pharmacology
researchProduct

Antioxidants as treatment for neurodegenerative disorders.

2002

Oxidative stress is a ubiquitously observed hallmark of neurodegenerative disorders. Neuronal cell dysfunction and cell death due to oxidative stress may causally contribute to the pathogenesis of progressive neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, as well as acute syndromes of neurodegeneration, such as ischaemic and haemorrhagic stroke. Neuroprotective antioxidants are considered a promising approach to slowing the progression and limiting the extent of neuronal cell loss in these disorders. The clinical evidence demonstrating that antioxidant compounds can act as protective drugs in neurodegenerative disease, however, is still relatively scarce. …

PharmacologyPathologymedicine.medical_specialtyParkinson's diseaseFree Radicalsbusiness.industryNeurodegenerationNeurodegenerative DiseasesGeneral MedicineDiseasemedicine.diseaseBioinformaticsmedicine.disease_causeNeuroprotectionAntioxidantsDrug developmentHuntington's diseaseMedicineAnimalsHumansPharmacology (medical)Amyotrophic lateral sclerosisbusinessOxidative stressExpert opinion on investigational drugs
researchProduct

Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids.

2000

Breakdown of cellular membranes is a characteristic feature of neuronal degeneration in acute (stroke) and chronic (senile dementia) neurological disorders. The present review summarizes recent experimental and clinical work which concentrated on changes of choline-containing phospholipids as indicators of neuronal membrane breakdown. Experimental studies identified glutamate release, calcium influx, and activation of cellular phospholipase A2 (PLA2) as important steps initiating membrane breakdown in cultured neurons or brain slices under hypoxic or ischemic conditions. Proton NMR studies have shown an elevation of choline-containing compounds in the brain of Alzheimer patients while neuro…

PhospholipidPhospholipasechemistry.chemical_compoundNeurochemicalPhospholipase A2PhosphatidylcholinemedicineCholineAnimalsHumansBiological PsychiatrybiologyChemistryNeurodegenerationCell MembraneGlutamate receptorNeurodegenerative Diseasesmedicine.diseasePsychiatry and Mental healthNeurologyBiochemistryAcute DiseaseChronic Diseasebiology.proteinPhosphatidylcholinesNeurology (clinical)Journal of neural transmission (Vienna, Austria : 1996)
researchProduct

Therapeutic potential of dietary polyphenols against brain ageing and neurodegenerative disorders

2010

In recent years there has been a growing interest, supported by a large number of experimental and epidemiological studies, in the beneficial effects of some commonly used food-derived products in preventing various age-related pathologic conditions, ranging from cancer to neurodegenerative diseases. Spices and herbs often contain active phenolic substances endowed with potent antioxidative and chemopreventive properties. Curcumin is a phytochemical compound extracted from the rhizome of Curcuma Longa. It is the pigment responsible for the characteristic yellow color of Indian curry. Data from our and other laboratories demonstrated that curcumin, as well as some other polyphenols, strongly…

PolyphenolAgingCurcuminNeuroprotective AgentDiseasePharmacologyAntioxidantsCatechinchemistry.chemical_compoundCaffeic AcidsPhenolsCellular stress responseMedicineCurcumaAntioxidants; Caffeic Acids; Catechin; Curcumin; Flavonoids; Neuroprotective Agents; Phenols; Phenylethyl Alcohol; Polyphenols; Aging; Brain; Diet; Neurodegenerative DiseasesFlavonoidsbiologyPhenolbusiness.industryPolyphenolsBrainNeurodegenerative DiseasesPhenylethyl Alcoholbiology.organism_classificationDietHeme oxygenaseNeuroprotective AgentschemistryPhytochemicalCaffeic AcidAgeingPhase II DetoxificationCurcuminFlavonoidAntioxidantbusiness
researchProduct

The unsolved relationship of brain aging and late-onset Alzheimer disease.

2009

Late-onset Alzheimer disease is the most common form of dementia and is strongly associated with age. Today, around 24 million people suffer from dementia and with aging of industrial populations this number will significantly increase throughout the next decades. An effective therapy that successfully decelerates or prevents the progressive neurodegeneration does not exist. Histopathologically Alzheimer disease is characterized by extensive extracellular amyloid beta (Abeta) plaques, intracellular neurofibrillary tangles (NFTs), synaptic loss and neuronal cell death in distinct brain regions. The molecular correlation of Abeta or NFTs and development of late-onset Alzheimer disease needs f…

Programmed cell deathAgingAmyloid βFree RadicalsBiophysicsmedicine.disease_causeBiochemistryModels BiologicalAtrophyAlzheimer DiseasemedicineExtracellularDementiaAnimalsHumansMolecular BiologyAmyloid beta-Peptidesbusiness.industryBrainNeurodegenerative Diseasesmedicine.diseaseDementiaAlzheimer's diseasebusinessNeuroscienceOxidative stressIntracellularBiochimica et biophysica acta
researchProduct

Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders

2011

In recent years, there has been a growing interest, supported by a large number of experimental and epidemi-ological studies, for the beneficial effects of some phenolic substances, contained in commonly used spices and herbs, in preventing various age-related pathologic conditions, ranging from cancer to neurodegenerative diseases. Although the exact mechanisms by which polyphenols promote these effects remain to be elucidated, several reports have shown their ability to stimulate a general xenobiotic response in the target cells, activating multiple defense genes. Data from our and other laboratories have previously demonstrated that curcumin, the yellow pigment of curry, strongly induces…

Programmed cell deathAntioxidantCurcuminNF-E2-Related Factor 2medicine.medical_treatmentCentral nervous systemNeuroscience (miscellaneous)InflammationPharmacologyBiologyResponse ElementsHeterodimers of NF-E2-related factors 2(Nrf2) Antioxidant responsive element (ARE) Heme oxygenase 1 (HO-1) Neurodegenerative disorders Alzheimer’s disease Polyphenols Curcumin (-)- epigallocatechin-3- gallate (EGCG) Brain ageingNeuroprotectionAntioxidantsCatechinArticleCellular and Molecular Neurosciencechemistry.chemical_compoundmedicineAnimalsHumansCognitive declineCaffeic acid phenethyl esterSettore MED/04 - Patologia GeneraleMolecular StructurePolyphenolsNeurodegenerative DiseasesDietmedicine.anatomical_structureNeuroprotective AgentsNeurologyBiochemistrychemistryFoodCurcuminmedicine.symptomCognition DisordersHeme Oxygenase-1
researchProduct

Ferroptosis Meets Cell–Cell Contacts

2021

Ferroptosis is a regulated form of cell death characterized by iron dependency and increased lipid peroxidation. Initially assumed to be selectively induced in tumour cells, there is increasing evidence that ferroptosis plays an important role in pathophysiology and numerous cell types and tissues. Deregulated ferroptosis has been linked to human diseases, such as neurodegenerative diseases, cardiovascular disorders, and cancer. Along these lines, ferroptosis is a promising pathway to overcoming therapy resistance of cancer cells. It is therefore of utmost importance to understand the cellular signalling pathways and the molecular mechanisms underlying ferroptosis regulation, including cont…

Programmed cell deathCell typeSomatic cellQH301-705.5ReviewCell CommunicationBiologyepithelial–mesenchymal transitionNeoplasmsmedicineAnimalsHumansEpithelial–mesenchymal transitionBiology (General)Calcium signalingFerroptosisCancerNeurodegenerative DiseasesGeneral Medicinecell–cell contactsmedicine.diseaseferroptosisCardiovascular DiseasesCancer cellcancer therapyNeuroscienceCells
researchProduct

The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular Stress.

2012

Cells are constantly exposed to endogenous and exogenous cellular injuries. They cope with stressful stimuli by adapting their metabolism and activating various “guardian molecules.” These pro-survival factors protect essential cell constituents, prevent cell death, and possibly repair cellular damages. The Inhibitor of Apoptosis (IAPs) proteins display both anti-apoptotic and pro-survival properties and their expression can be induced by a variety of cellular stress such as hypoxia, endoplasmic reticular stress and DNA damage. Thus, IAPs can confer tolerance to cellular stress. This review presents the anti-apoptotic and survival functions of IAPs and their role in the adaptive response to…

Programmed cell deathDNA damageCellCellular homeostasisReviewUPRInhibitor of apoptosisDNA damage responseNF-κBneurodegenerative diseaseMedicinecancerNF-kBlcsh:QH301-705.5Caspasebiologybusiness.industryEndoplasmic reticulumapoptosisGeneral MedicineCell biologyIAPsmedicine.anatomical_structurelcsh:Biology (General)caspasesApoptosisImmunologyTNFRbiology.proteinbusinessCells
researchProduct